Ozempic is changing how Americans spend money, and the numbers are startling
Millions of Americans are spending potentially hundreds of dollars each month on GLP-1 medications, but that comes at a cost: Their weight-loss journey is shaking up how they spend their money. In the five years since these medications were approved for chronic weight management by the Food and Drug Administration , they’ve grown in popularity, such that an estimated 11% of American adults are…
Ozempic and similar GLP-1 medications have reshaped the spending habits of millions of Americans. Five years after these drugs received FDA approval for chronic weight management, about 11% of American adults currently take a GLP-1 medication to shed pounds. This trend has led to noticeable changes in various industries, while some impacts remain less apparent.
The apparel industry has seen a 26% increase in spending among GLP-1 users, as many individuals embrace a "treat yo self" mentality once they begin losing weight. Denim purchases have skyrocketed by 66%, while swimwear sales have risen 31%. However, the relationship between regaining lost weight and the tailoring industry is less clear.
Alan David Custom, a fifth-generation bespoke suit-maker, has experienced a surge in business due to the weight-loss journey, only to face challenges as clients regain weight and require alterations.
The fitness industry has also felt the effects of GLP-1 medications. While 36% of users exercise more frequently, 14% have decreased their attendance at group fitness classes, and only 11% have increased their participation. This shift has prompted gym chains like PureGym, Planet Fitness, and The Gym Group to allocate more floor space to strength and functional training.
The airline industry has benefited from a potential $580 million in annual savings if 178 passengers on a Boeing 737 plane collectively lose 10% of their body weight. Airlines are seeking cost containment, and this could be significant given the high cost of fuel. However, the reduced weight may also lead to a decrease in in-flight snacks and alcohol purchases.
Food spending patterns have undergone a significant transformation as well. Quick-service restaurants have experienced a near 9% decrease in household spending after 6 to 8 months of GLP-1 use. Weekly pizza nights have become less popular, with spending dropping by 22% during this period. Grocery store sales have also shifted, with 61% of GLP-1 users buying fewer sweet treats, and a decline in sugary drink and alcohol sales.
Despite this, Americans on these medications are focusing on healthier options, such as fresh produce, protein, and items like Greek yogurt, jerky, and nutrition bars. This indicates a serious commitment to their weight-loss journey while on the medications, even if many struggle to maintain the weight loss afterwards.
Written by urgent.news from Fast Company's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
